中性粒细胞来源脂质运载蛋白-2作为成人斯蒂尔病疾病活动度和肝损伤的新型生物标志物
本研究通过转录组分析发现成人斯蒂尔病(AOSD)患者中性粒细胞中脂质运载蛋白-2(LCN2)表达上调,并在血浆和肝活检组织中验证。血浆LCN2水平与炎症指标、系统评分及细胞因子相关,且在伴有肝受累的活动性AOSD中升高,与肝功能障碍独立相关,鉴别AOSD肝损伤的AUC达0.9694。
要点
- AOSD患者中性粒细胞LCN2在mRNA和蛋白水平均上调。
- 血浆LCN2与炎症标志物、系统评分、HScore及细胞因子密切相关。
- LCN2可识别AOSD伴肝损伤,AUC为0.9694。
核心结论
- 中性粒细胞来源的LCN2在AOSD患者血浆和肝组织中升高,可作为识别AOSD系统炎症尤其是高炎症所致肝损伤的潜在生物标志物。
研究设计与样本
- 对未治疗的活动的AOSD患者和健康供者进行中性粒细胞转录组分析,并在中性粒细胞、血浆和肝活检组织中评估LCN2表达。
- 分析LCN2与不同变量的相关性及其识别AOSD患者肝损伤的能力。
主要发现
- RNA测序发现LCN2在AOSD中性粒细胞中上调,并在mRNA和蛋白水平得到确认。
- AOSD患者血浆LCN2水平显著高于健康对照、RA和SLE患者。
- 血浆LCN2水平与炎症标志物、系统评分、HScore和细胞因子密切 correlated。
- 伴有肝受累的活动性AOSD中LCN2水平升高,且与肝功能障碍独立相关。
- 三例持续肝损伤患者的肝活检中检测到LCN2表达增强。
关键数值与推荐
- LCN2识别AOSD伴肝损伤与其他肝病的AUC值为0.9694。
临床怎么用
- 血浆LCN2可能有助于识别AOSD伴系统炎症和肝损伤,尤其在高炎症导致的肝损害评估中具有潜在应用价值。
局限性
- 肝活检仅在三名持续肝损伤患者中进行,样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Liver damage is a common manifestation and can be life-threatening in adult-onset Still's disease (AOSD), an autoinflammatory disease. The hallmark of AOSD is activation of neutrophils, whose infiltration in liver is suspected to promote tissue injury. Here we aimed to identify a candidate biomarker and to validate its association with liver damage in AOSD. METHODS: Transcriptome analysis of neutrophils from treatment-naïve active AOSD patients and healthy donors was performed. Lipocalin-2 (LCN2) expression was assessed in neutrophils, plasma and liver biopsies of AOSD. The correlations of LCN2 with different variables and its ability to identify liver damage from AOSD patients were analysed. RESULTS: LCN2, a novel biomarker in hepatic inflammation, was found to be upregulated in AOSD neutrophils by RNA sequencing and confirmed at the mRNA and protein levels. Plasma levels of LCN2 were significantly higher in AOSD patients than healthy controls, RA and SLE patients. Plasma LCN2 levels were closely correlated with inflammatory markers, systemic score, HScore and cytokines. Moreover, LCN2 levels were increased in active AOSD with liver involvement and independently associated with liver dysfunction. Enhanced expression of LCN2 was detected in liver biopsies from three patients with ongoing liver injury. Furthermore, the area under the curve value of LCN2 for identifying AOSD with liver injury from other liver diseases was 0.9694. CONCLUSION: Our results reveal that neutrophils-derived LCN2 is higher in plasma and liver tissue in AOSD patients than in healthy controls, and it could serve as a potent biomarker for identifying AOSD with systemic inflammation, especially liver damage caused by hyperinflammation.
引用
- Jia J, Yang L, Cao Z, et al. Neutrophil-derived lipocalin-2 in adult-onset Still's disease: a novel biomarker of disease activity and liver damage. Rheumatology (Oxford). 2021. PMID: 32766690. doi:10.1093/rheumatology/keaa368
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。